Cancer Family
Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000023Explore in graph →
HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000023Explore in graph →
Clinical trials
18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01570049 | Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma | unknown | Phase 3 | 100 | Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01572688 | Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma(MM) | unknown | N/A | 60 | Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY | 1 | Aug 2, 2012 |
| NCT00503594 | Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine(CNSLymphoma) | unknown | Phase 2 | 92 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00091234 | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia(AML-19) | unknown | Phase 2 / Phase 3 | 279 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 24, 2012 | clinicaltrials |
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia(AML-14A) | unknown | Phase 1 / Phase 2 | 114 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 20, 2012 | clinicaltrials |
| NCT01134484 | VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM) | unknown | Phase 3 | 480 | Michele CavoOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00463463 | Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma(Zevalin) | unknown | Phase 3 | — | Soroka University Medical CenterOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT01633099 | Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients | unknown | Phase 3 | 46 | Jianxiang WangUNKNOWN | 0 | Jul 6, 2012 | clinicaltrials |
| NCT01627132 | Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial | unknown | Phase 2 | 50 | Shimousa Hematology Study GroupOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT01330342 | Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma(SSAT042) | unknown | — | 40 | St Stephens Aids TrustOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT01295593 | Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) | unknown | Phase 1 / Phase 2 | 33 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00998270 | Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma | unknown | Phase 2 / Phase 3 | 185 | Tehran University of Medical SciencesOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01015742 | Unrelated Double Umbilical Cord Blood Units Transplantation | unknown | Phase 2 / Phase 3 | 10 | Tehran University of Medical SciencesOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01010243 | Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial(MM03) | unknown | Phase 1 / Phase 2 | 54 | University of RegensburgOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00111345 | Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents | unknown | Phase 2 / Phase 3 | 550 | University Hospital MuensterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT01603290 | Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients | unknown | — | 130 | National Taiwan University HospitalOTHER | 1 | May 22, 2012 | clinicaltrials |
| NCT01314625 | A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients | unknown | — | 10 | University of ArkansasOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00725231 | Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP(A-CHOP-14) | unknown | Phase 3 | 274 | University of GöttingenOTHER | 1 | May 7, 2012 | clinicaltrials |
| NCT00887042 | Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML | unknown | Phase 1 / Phase 2 | 35 | The Korean Society of Pediatric Hematology OncologyNETWORK | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01556477 | The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q). | unknown | Phase 2 | 72 | Nordic MDS GroupNETWORK | 1 | Mar 16, 2012 | clinicaltrials |
| NCT01555359 | Telomerase Activity as a Marker For Mobilization Quality | unknown | — | 50 | Rabin Medical CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00445822 | Registration of Children With CML and Treatment With Imatinib(CML-paed II) | unknown | — | 150 | Technische Universität DresdenOTHER | 1 | Feb 29, 2012 | clinicaltrials |
| NCT00933673 | New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma | unknown | Phase 2 | 76 | Fudan UniversityOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT01534702 | Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML(CIARA) | unknown | Phase 1 / Phase 2 | 60 | Hannover Medical SchoolOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT01180426 | Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia | unknown | Phase 2 | 30 | Chroma TherapeuticsINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT01532856 | Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years | unknown | Phase 3 | 64 | Grupo de Estudos Multicentricos em Onco-HematologiaNETWORK | 1 | Feb 15, 2012 | clinicaltrials |
| NCT01533779 | Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity | unknown | — | 50 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00091676 | Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma(BiovaxID) | unknown | Phase 3 | 629 | Biovest InternationalINDUSTRY | 0 | Feb 3, 2012 | clinicaltrials |
| NCT01310933 | Ultrasonographic Differentiation Between Kikuchi's Disease and Lymphoma in Patients With Cervical Lymphadenopathy | unknown | — | 40 | Far Eastern Memorial HospitalOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01513109 | Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia(ASCI) | unknown | Phase 1 / Phase 2 | 20 | Jules Bordet InstituteOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01513603 | Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia | unknown | Phase 2 | 50 | New York Medical CollegeOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00156858 | Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study | unknown | N/A | 200 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT01509300 | HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors | unknown | Phase 1 / Phase 2 | 10 | Asan Medical CenterOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00400907 | Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9 | unknown | — | 667 | German High-Grade Non-Hodgkin's Lymphoma Study GroupOTHER | 0 | Dec 20, 2011 | clinicaltrials |
| NCT00538278 | Prospective Database for Acute Myeloblastic Leukemia | unknown | N/A | 2,000 | King Faisal Specialist Hospital & Research CenterOTHER | 0 | Dec 13, 2011 | clinicaltrials |
| NCT00538447 | Prospective Database for Chronic Myelogenous Leukemia | unknown | N/A | 2,000 | King Faisal Specialist Hospital & Research CenterOTHER | 0 | Dec 13, 2011 | clinicaltrials |
| NCT00538551 | Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases | unknown | — | 350 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01310946 | Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology | unknown | — | 203 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01490957 | Functional Assessment of Cancer Therapy - Bone Marrow Transplant(FACT-BMT) | unknown | — | 113 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00866762 | A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 4 | Dec 12, 2011 | clinicaltrials |
| NCT01227135 | Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia | unknown | Phase 2 | 66 | Lynn McMahonOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT01470066 | Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell Lymphomas | unknown | — | 80 | Chonnam National University HospitalOTHER | 1 | Nov 11, 2011 | clinicaltrials |
| NCT01467024 | Evaluation of the MP Diagnostics HTLV Blot 2.4 | unknown | — | 600 | MP Biomedicals, LLCINDUSTRY | 1 | Nov 8, 2011 | clinicaltrials |
| NCT01302912 | Lymphoma in the Orbit | unknown | — | 50 | University of ZurichOTHER | 1 | Nov 4, 2011 | clinicaltrials |
| NCT01464411 | Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan(D-First) | unknown | — | 40 | Kanto CML Study GroupOTHER | 1 | Nov 3, 2011 | clinicaltrials |
| NCT00932854 | A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)(REMEDY) | unknown | N/A | 75 | University College London HospitalsOTHER | 1 | Oct 18, 2011 | clinicaltrials |
| NCT00907348 | Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma(REAL07) | unknown | Phase 2 | 49 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01009970 | Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma | unknown | Phase 2 | 50 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Oct 13, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Aug 2, 2012source: clinicaltrials